| 产品描述: | Immunoproteasome inhibitor 1 is a potent, reversible, time-independent immunoproteasome and proteasome inhibitor (Kis of 1.18, 0.27, 1.91 μM in β5c, β1i, β5i submits, respectively). Immunoproteasome inhibitor 1 can be used for the research of certain neoplastic diseases. |
| 靶点: |
β5c submit:1.18 μM (Ki); β1i submit:0.27 μM (Ki); β2i submit:20 μM (Ki); β5i submit:1.91 μM (Ki) |
| 体内研究: |
Immunoproteasome inhibitor 1 (compound 9) (0-25 μM; 0-600 seconds; in Human 20S immunoproteasome and human 20S proteasome) has high binding affinity for the β1i subunit (0.27 µM) of immunoproteasome and proteasome, coupling with good inhibitory properties towards β5i and β5c subunits. And the results of against the β5i subunit shows that the inhibition is reversible, time-independent. |
| 保存条件: |
-80°C 6个月; -20°C 1个月,避光 |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
2.79 ml |
13.95 ml |
27.899 ml |
| 5 mM |
0.558 ml |
2.79 ml |
5.58 ml |
| 10 mM |
0.279 ml |
1.395 ml |
2.79 ml |
| 50 mM |
0.056 ml |
0.279 ml |
0.558 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |